Abraham Ceesay
CIK 1722140 · Chief Executive Officer · last filed 2026-05-11
Abraham Ceesay is a Chief Executive Officer who has filed 23 SEC Form 4 insider transactions across 6 companies since 2018. The most recent filing shows the insider was granted $255.4K of CRL on May 11, 2026. Across all open-market trades the lifetime net is −$6.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $22.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$22.90M
6
23
-$6.82M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRL | Director | 2,384 | $187.51 | $447.0K | $0 | 2 | 2026-05-11 |
| RAPP | Chief Executive Officer | 579,257 | $38.40 | $22.24M | -$3.50M | 9 | 2026-02-19 |
| PCRX | Director | 9,039 | $22.99 | $207.8K | -$64.0K | 4 | 2025-09-08 |
| Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | President | 19,210 | $44.96 | $863.7K | -$3.26M | 6 | 2023-02-08 |
| Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted | President | — | $18.07 | — | $0 | 1 | 2021-06-03 |
| scPharmaceuticals Inc. (SCPH) Delisted | Chief Operating Officer | — | $5.67 | — | $0 | 1 | 2018-01-19 |
Recent Filings
23 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-11 | CRL | Grant (A) | +1,438 | $255.4K | EDGAR |
| 2026-02-19 | RAPP | Sell (S) | −10,916 | -$320.4K | EDGAR |
| 2026-02-04 | RAPP | Grant (A) | — | $0 | EDGAR |
| 2026-01-22 | RAPP | Sell (S) | −10,916 | -$285.1K | EDGAR |
| 2025-12-18 | RAPP | Sell (S) | −10,916 | -$323.5K | EDGAR |
| 2025-11-18 | RAPP | Sell (S) | −10,916 | -$275.0K | EDGAR |
| 2025-10-16 | RAPP | Sell (S) | −10,916 | -$281.7K | EDGAR |
| 2025-09-19 | RAPP | Sell (S) | −76,420 | -$2.01M | EDGAR |
| 2025-09-08 | PCRX | Sell (S) | −2,354 | -$64.0K | EDGAR |
| 2025-06-13 | PCRX | Grant (A) | +6,163 | $0 | EDGAR |